NADIA TROCHANOVA: Open Payments
NPI 1265858146 · WOODLAND HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 10 payments from 8 companies in 2025. Trend: 2023 $761 · 2024 $118 · 2025 $1,137
Food & beverage: $1,137
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $223 |
| Amgen Inc. | 1 | $150 |
| Genentech, Inc. | 1 | $142 |
| E.R. Squibb & Sons, L.L.C. | 1 | $132 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| ARGENX US, INC. | 1 | $122 |
| Biogen, Inc. | 1 | $118 |
Products named: REPATHA, COBENFY, LOKELMA, VYVGART, ZURZUVAE.
Industry payments across CA — which companies pay providers there.
